Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-412601
Filing Date
2026-10-02
Accepted
2026-10-02 17:16:47
Documents
1
Period of Report
2026-10-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d57016ddef14a.htm DEF 14A 405709
  Complete submission text file 0001193125-26-412601.txt   406784
Mailing Address 333 SOUTH GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071 213-830-6300
Oaktree Acquisition Corp. III Life Sciences (Filer) CIK: 0002029769 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-42383 | Film No.: 261437883
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)